483 Daiichi Sankyo Chemical Pharma Jan 2019

483 Daiichi Sankyo Chemical Pharma Jan 2019

Zachary Stamm FDA$119.00 - Available Now

FDA investigators audited the Daiichi Sankyo Chemical Pharma - Odawara, Japan facility and issued inspectional observations (via FDA 483) on 25 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jan 2019
  • Location: Odawara, Japan
  • FEI: 3003279188
Add To Cart